Navigation Links
Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
Date:3/11/2008

LAS VEGAS, March 11 /PRNewswire/ -- Altogen Biosystems (http://www.altogen.com) announced launch of new contract research services. Located in Las Vegas, NV, Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, including RNA Interference (RNAi) services, generation of stably-expressing cell lines, assay development, screening and transfection services. In particular, the company will draw upon their unique experience with over hundred cancer cell lines and expertise in polymer and nanoparticle-based gene delivery technologies.

Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Utilizing this method, investigators are able to develop cells that permanently express specific genes through their incorporation in the cellular genome. Altogen Custom Services offers generation of stable cell lines by transforming the cell line of choice to stably express vector or gene of interest. Optional cloning and shRNA expression services are available. The service turnaround time is typically 3-4 weeks.

Altogen laboratory research services (http://www.altogen.com/support.htm) include:

-- Transfection services (transient and stable)

-- Assay development and library screening

-- Cloning and plasmid vector construction

-- Generation of stable cell lines

-- RNAi experiments (siRNA design, synthesis, validation)

-- Gene targeting (mRNA knockdown, shRNA overexpression)

-- Custom services

About Altogen Biosystems

Altogen Biosystems is a life sciences company dedicated to the development, marketing and manufacture of In Vivo and In Vitro transfection reagents for intracellular and tissue-targeted delivery of biomolecules. Altogen Custom Services is a laboratory contract research organization. It provides specialized contract research to pharmaceutical, biotechnology, and other life science organizations worldwide. For more information visit http://www.altogen.com


'/>"/>
SOURCE Altogen Biosystems
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
2. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
3. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
4. Primera Biosystems Raises $21 Million in Series B Private Round
5. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
6. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
7. Moleac Launches NeuroAid10(TM) in the United States
8. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
9. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
10. BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services
11. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Wound Market with the addition of its newest module, US Hemostats & Sealants. ... for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used ...
(Date:10/11/2017)... Charlotte, N.C. (PRWEB) , ... October 11, 2017 ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the ... Laboratories ( ASTER Labs ), Inc. has been selected for membership in ...
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
Breaking Biology Technology:
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):